GLP-1 and Intestinal Diseases

Accumulating evidence implicates glucagon-like peptide-1 (GLP-1) to have, beyond glucose maintenance, a beneficial role in the gastrointestinal tract. Here, we review emerging data investigating GLP-1 as a novel treatment for intestinal diseases, including inflammatory bowel diseases, short-bowel sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunt, Jenna Elizabeth, Holst, Jens Juul, Jeppesen, Palle Bekker, Kissow, Hannelouise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067135/
https://www.ncbi.nlm.nih.gov/pubmed/33916501
http://dx.doi.org/10.3390/biomedicines9040383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067135/
https://www.ncbi.nlm.nih.gov/pubmed/33916501
http://dx.doi.org/10.3390/biomedicines9040383

Ejemplares similares